Systematic review and meta-analysis of randomised controlled trials testing the effects of vitamin C supplementation on blood lipids

被引:41
作者
Ashor, Ammar W. [1 ,2 ]
Siervo, Mario [1 ,3 ]
van der Velde, Femke [1 ]
Willis, Naomi D. [1 ]
Mathers, John C. [1 ]
机构
[1] Newcastle Univ, Inst Cellular Med, Human Nutr Res Ctr, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, England
[2] Univ Al Mustansiriyah, Coll Med, Baghdad, Iraq
[3] MRC Human Nutr Res, Elsie Widdowson Labs, 120 Fulbourn Rd, Cambridge CB1 9NL, England
基金
英国医学研究理事会;
关键词
Ascorbic acid; Cholesterol; Triglycerides; Lipoproteins; Nutritional supplements; Cardiovascular risk; PLASMA ASCORBIC-ACID; SERUM-LIPIDS; CARDIOVASCULAR RISK; OXIDATIVE STRESS; SHORT-TERM; ANTIOXIDANT; CHOLESTEROL; DISEASE; PRESSURE; EFFICACY;
D O I
10.1016/j.clnu.2015.05.021
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Randomised controlled trials (RCTs) in humans revealed contradictory results regarding the effect of vitamin C supplementation on blood lipids. We aimed to conduct a systematic review and meta-analysis of RCTs investigating the effect of vitamin C supplementation on total cholesterol, low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C) and triglycerides and to determine whether the effects are modified by the participants' or intervention characteristics. Methods: Four databases (PubMed, Embase, Scopus and Cochrane Library) were searched from inception until August 2014 for RCTs supplementing adult participants with vitamin C for >= 2 weeks and reporting changes in blood lipids. Results: Overall, vitamin C supplementation did not change blood lipids concentration significantly. However, supplementation reduced total cholesterol in younger participants (<= 52 years age) (-0.26 mmol/L, 95% CI: -0.45, -0.07) and LDL-C in healthy participants (-0.32 mmol/L, 95% CI: -0.57, -0.07). In diabetics, vitamin C supplementation reduced triglycerides significantly (-0.15 mmol/L, 95% CI: -0.30, -0.002) and increased HDL-C significantly (0.06 mmol/L, 95% CI: 0.02, all). Meta-regression analyses showed the changes in total cholesterol (beta: -0.24, CI: -0.36, -0.11) and in triglycerides (beta: -0.17, CI: -0.30, -0.05) following vitamin C supplementation were greater in those with higher concentrations of these lipids at baseline. Greater increase in HDL-C was observed in participants with lower baseline plasma concentrations of vitamin C (beta: -0.002, CI: -0.003, -0.0001). Conclusions: Overall, vitamin C supplementation had no significant effect on lipid profile. However, subgroup and sensitivity analyses showed significant reductions in blood lipids following supplementation in sub-populations with dyslipidaemia or low vitamin C status at baseline. PROSPERO Database registration: CRD42014013487, http://www.crd.york.ac.uk/prospero/. (C) 2015 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:626 / 637
页数:12
相关论文
共 66 条
[1]   Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes [J].
Abdel-Maksoud, Madiha ;
Sazonov, Vasilisa ;
Gutkin, Stephen W. ;
Hokanson, John E. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 51 (04) :331-351
[2]   Effect of Vitamin C Supplementation on Oxidative Stress and Lipid Profiles in Hemodialysis Patients [J].
Abdollahzad, Hadi ;
Eghtesadi, Shahriar ;
Nourmohammadi, Issa ;
Khadem-Ansari, Mohammadhasan ;
Nejad-Gashti, Hossein ;
Esmaillzadeh, Ahmad .
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2009, 79 (5-6) :281-287
[3]  
[Anonymous], 2012, INT J DIABETES METAB
[4]  
[Anonymous], COCHRANE HDB SYSTEMA
[5]   NO EFFECT ON SERUM-LIPIDS BY MODERATE AND HIGH-DOSES OF VITAMIN-C IN ELDERLY SUBJECTS WITH LOW PLASMA ASCORBIC-ACID LEVELS [J].
ARO, A ;
KYLLASTINEN, M ;
KOSTIAINEN, E ;
GREF, CG ;
ELFVING, S ;
UUSITALO, U .
ANNALS OF NUTRITION AND METABOLISM, 1988, 32 (03) :133-137
[6]   Antioxidant Vitamin Supplementation Reduces Arterial Stiffness in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J].
Ashor, Ammar W. ;
Siervo, Mario ;
Lara, Jose ;
Oggioni, Clio ;
Mathers, John C. .
JOURNAL OF NUTRITION, 2014, 144 (10) :1594-1602
[7]  
Askari G, 2013, INT J PREVENTIVE MED, V4, pS58
[8]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[9]  
Bhatt JK., 2012, Int J Pharm Sci, V4, P524
[10]  
Bishop N, 1985, Diabet Med, V2, P121